Novo Nordisk Axes 400 Jobs At Troubled Bloomington Plant

About 400 people at Novo Nordisk's Bloomington manufacturing plant are set to lose their jobs, roughly one in five roles at the site, with layoffs expected to begin in early May. The drugmaker confirmed the cuts yesterday, adding another jolt to a facility that has already had a rough couple of years.

The cuts were first detailed by the Indianapolis Business Journal, which reported the company will offer severance, outplacement assistance and transition support to affected employees. Neither the company nor local officials have released a full list of which departments will be hit.

Plant history and regulatory trouble

The Bloomington facility was folded into Novo Nordisk's operations after the company and its affiliates acquired parts of Catalent's network late in 2024. That transition did not wipe away long-standing problems at the site.

An FDA inspection in mid-2025 resulted in a Form 483, and the agency later issued a warning letter that cited inadequate investigations and contamination risks, according to Fierce Pharma.

City response and worker support

The City of Bloomington acknowledged the planned reductions after site leadership notified Mayor Kerry Thomson. "Our focus is on the individuals affected," the mayor said in a city statement.

The city said it will work to connect laid-off employees with other work and support services, according to reporting from the Indiana Daily Student.

Why now: corporate restructuring and market pressure

Novo Nordisk has been slimming its global payroll as part of a company-wide restructuring. Industry reporting notes the company announced plans in September 2025 to cut roughly 9,000 roles as it retooled to compete in the crowded GLP-1 obesity market.

That broader corporate program, combined with the Bloomington site's regulatory headaches, helps explain why leadership is targeting local headcount now, industry analysts say, according to Fierce Pharma.

What’s next for workers

Local reporting and employee discussions that surfaced online indicate there is still confusion about timing and which departments will be affected, with some workers saying notifications will arrive later. The Bloomingtonian reported those conversations and noted Novo Nordisk did not provide that outlet the same statement it shared with other local reporters, leaving some specifics incomplete.

Novo Nordisk, the city and local workforce groups say they will provide more information and support as notifications are delivered. This story will be updated as officials and the company publish additional details.